Table 3.
VAS (resting pain and movement pain) evolution between the beginning and end of the physiotherapeutic program (12 weeks).
| TELEREHAB | IN-PRESENCE | Inter-Group Difference p-Value |
Effect Size | |
|---|---|---|---|---|
| RESTING PAIN | ||||
| Baseline | 2.2 ± 0.1 | 1.7 ± 0.4 | ||
| 12 weeks | 0.8 ± 0.2 | 0.6 ± 0.1 | ||
| Δ 12 weeks—Baseline | −1.4 ± 0.2 | −1.1 ± 0.5 | <0.01 | 0.27 |
| Intra-group changes p-value | <0.01 | <0.01 | ||
| MOVEMENT PAIN | ||||
| Baseline | 3.6 ± 0.5 | 3.2 ± 0.4 | ||
| 12 weeks | 1.6 ± 0.3 | 1.2 ± 0.3 | ||
| Δ 12 weeks—Baseline | −2 ± 0.6 | −2 ± 0.6 | 0.93 | <0.01 |
| Intra-group changes p-value | <0.01 | <0.01 |